二分类终点随机临床试验设计:2×2表的条件分析与非条件分析
本文讨论二分类终点随机临床试验中2×2表的条件分析与非条件分析对样本量需求的影响。Fisher精确检验的条件分析实际一类错误不超过名义水平,但Boschloo非条件检验至少同样有效且所需样本量更小。作者回顾支持条件分析的论据,认为在随机临床试验情境下这些论据不相关或不完全令人信服,提示非条件检验的样本量优势应支持其被推荐使用。
要点
- 二分类终点试验中,非条件检验相比Fisher精确检验所需样本量更小。
- Boschloo非条件检验至少与Fisher精确检验同样有效,且实际一类错误不超过名义水平。
- 作者认为支持条件分析(Fisher精确检验)的论据在随机临床试验情境下不相关或不完全令人信服。
核心结论
- 作者认为,在随机临床试验情境下,支持条件分析(Fisher精确检验)的论据不相关或不完全令人信服,非条件检验的样本量优势应支持其被推荐使用。
研究设计与样本
- 本文为方法学综述,讨论二分类终点随机临床试验中2×2表的条件分析与非条件分析对样本量需求的影响,未报告检索范围与样本量。
主要发现
- Fisher精确检验的条件分析实际一类错误小于或等于指定名义一类错误。
- Boschloo非条件检验至少与Fisher精确检验同样有效,且所需样本量更小。
- 作者认为支持条件分析的论据在随机临床试验情境下不相关或不完全令人信服。
关键数值与推荐
- 条件分析下Fisher精确检验的实际一类错误小于或等于指定名义一类错误。
- Boschloo非条件检验至少与Fisher精确检验同样有效,且所需样本量更小。
临床怎么用
- 作者建议非条件检验因其样本量优势应被推荐用于二分类终点随机临床试验的2×2表分析。
- 作者简要建议,由于试验设计者实际总是有目标零假设和备择假设应答率,可利用该信息提高非条件检验的效能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
When designing a randomized clinical trial to compare two treatments, the sample size required to have desired power with a specified type 1 error depends on the hypothesis testing procedure. With a binary endpoint (e.g., response), the trial results can be displayed in a 2 × 2 table. If one does the analysis conditional on the number of positive responses, then using Fisher's exact test has an actual type 1 error less than or equal to the specified nominal type 1 error. Alternatively, one can use one of many unconditional "exact" tests that also preserve the type 1 error and are less conservative than Fisher's exact test. In particular, the unconditional test of Boschloo is always at least as powerful as Fisher's exact test, leading to smaller required sample sizes for clinical trials. However, many statisticians have argued over the years that the conditional analysis with Fisher's exact test is the only appropriate procedure. Since having smaller clinical trials is an extremely important consideration, we review the general arguments given for the conditional analysis of a 2 × 2 table in the context of a randomized clinical trial. We find the arguments not relevant in this context, or, if relevant, not completely convincing, suggesting the sample-size advantage of the unconditional tests should lead to their recommended use. We also briefly suggest that since designers of clinical trials practically always have target null and alternative response rates, there is the possibility of using this information to improve the power of the unconditional tests.
引用
- Korn EL, Freidlin B. Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two-by-two table. Stat Med. 2024. PMID: 38780538. doi:10.1002/sim.10115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。